Longitudinal Effects of Adjuvant Endocrine Therapy on the Quality of Life of Post-menopausal Women with Non-metastatic ER Breast Cancer: A Systematic Review. (Q53841735)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Longitudinal Effects of Adjuvant Endocrine Therapy on the Quality of Life of Post-menopausal Women with Non-metastatic ER Breast Cancer: A Systematic Review.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 May 2018

http://europepmc.org/abstract/MED/29470807

Longitudinal Effects of Adjuvant Endocrine Therapy on the Quality of Life of Post-menopausal Women with Non-metastatic ER Breast Cancer: A Systematic Review (English)

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6249194&resulttype=core&format=json

13 May 2020

quality of life

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6249194&resulttype=core&format=json

13 May 2020

author name string

Xinyi Jiang

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6249194&resulttype=core&format=json

13 May 2020

Cheng Chen

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6249194&resulttype=core&format=json

13 May 2020

Alberto J Montero

4

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6249194&resulttype=core&format=json

13 May 2020

Vakaramoko Diaby

5

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6249194&resulttype=core&format=json

13 May 2020

publication date

22 February 2018

1 reference

Europe PubMed Central

PubMed publication ID

20 May 2018

http://europepmc.org/abstract/MED/29470807

PharmacoEconomics - Open

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6249194&resulttype=core&format=json

13 May 2020

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6249194&resulttype=core&format=json

13 May 2020

4

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6249194&resulttype=core&format=json

13 May 2020

359-369

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6249194&resulttype=core&format=json

13 May 2020

copyright license

Creative Commons Attribution-NonCommercial 4.0 International

22 February 2018

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

The Perceived Adjustment to Chronic Illness Scale (PACIS): a global indicator of coping for operable breast cancer patients in clinical trials. Swiss Group for Clinical Cancer Research (SAKK) and the International Breast Cancer Study Group (IBCSG).

1 reference

https://pubmed.ncbi.nlm.nih.gov/29470807

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

1 reference

https://pubmed.ncbi.nlm.nih.gov/29470807

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer: the International Breast Cancer Study Group Trial VII.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29470807

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

SF-36 health survey update

1 reference

https://pubmed.ncbi.nlm.nih.gov/29470807

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The visual analog scale for pain: clinical significance in postoperative patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/29470807

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessing quality of life in research and clinical practice

1 reference

https://pubmed.ncbi.nlm.nih.gov/29470807

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Selective estrogen-receptor modulators -- mechanisms of action and application to clinical practice.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29470807

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Health-related quality-of-life measurement in randomized clinical trials in breast cancer--taking stock

1 reference

https://pubmed.ncbi.nlm.nih.gov/29470807

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Health-related quality of life in axillary node-negative, estrogen receptor-negative breast cancer patients undergoing AC versus CMF chemotherapy: findings from the National Surgical Adjuvant Breast and Bowel Project B-23.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29470807

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quality of life of postmenopausal women in the Arimidex, Tamoxifen, Alone or in Combination (ATAC) Adjuvant Breast Cancer Trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/29470807

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29470807

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Toremifene and tamoxifen are equally effective for early-stage breast cancer: first results of International Breast Cancer Study Group Trials 12-93 and 14-93.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29470807

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/29470807

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessment of quality of life in MA.17: a randomized, placebo-controlled trial of letrozole after 5 years of tamoxifen in postmenopausal women

1 reference

https://pubmed.ncbi.nlm.nih.gov/29470807

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Exemestane after tamoxifen as adjuvant hormonal therapy in postmenopausal women with breast cancer: effects on body composition and lipids

1 reference

https://pubmed.ncbi.nlm.nih.gov/29470807

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quality of life of postmenopausal women in the ATAC ("Arimidex", tamoxifen, alone or in combination) trial after completion of 5 years' adjuvant treatment for early breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/29470807

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prospective study of long-term impact of adjuvant high-dose and conventional-dose chemotherapy on health-related quality of life

1 reference

https://pubmed.ncbi.nlm.nih.gov/29470807

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Benefit from exemestane as extended adjuvant therapy after 5 years of adjuvant tamoxifen: intention-to-treat analysis of the National Surgical Adjuvant Breast And Bowel Project B-33 trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29470807

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy, toxicity, and quality of life in older women with early-stage breast cancer treated with letrozole or placebo after 5 years of tamoxifen: NCIC CTG intergroup trial MA.17.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29470807

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Health-related quality of life in breast cancer patients: a bibliographic review of the literature from 1974 to 2007.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29470807

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A menopause-specific quality of life questionnaire: development and psychometric properties

1 reference

https://pubmed.ncbi.nlm.nih.gov/29470807

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

1 reference

https://pubmed.ncbi.nlm.nih.gov/29470807

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/29470807

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quality-of-life measurement in randomized clinical trials in breast cancer: an updated systematic review (2001-2009).

1 reference

https://pubmed.ncbi.nlm.nih.gov/29470807

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Health-related quality of life and psychological distress of breast cancer patients after surgery during a phase III randomized trial comparing continuation of tamoxifen with switching to anastrozole after adjuvant tamoxifen for 1-4 years: N-SAS BC

1 reference

https://pubmed.ncbi.nlm.nih.gov/29470807

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/29470807

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Health-related quality of life, psychological distress, and adverse events in postmenopausal women with breast cancer who receive tamoxifen, exemestane, or anastrozole as adjuvant endocrine therapy: National Surgical Adjuvant Study of Breast Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/29470807

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interrater reliability: the kappa statistic.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29470807

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years

1 reference

https://pubmed.ncbi.nlm.nih.gov/29470807

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S41669-018-0070-7

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6249194&resulttype=core&format=json

13 May 2020

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6249194&resulttype=core&format=json

13 May 2020

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6249194&resulttype=core&format=json

13 May 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53841735&oldid=2212305871"